Cancer news

Latest news, press releases and blog posts from Cancer Research UK.


Mesothelioma Awareness Day: How research is tackling the deadly legacy of asbestos

A greater understanding of the biology of mesothelioma has led to new clinical trials testing immunotherapies and targeted drugs against the disease.

Cancer Research UK and Biotecnol to trial new immuno-oncology treatment for advanced tumours

Cancer Research UK and Biotecnol Limited will trial an experimental immuno-oncology treatment for some patients with advanced tumours.

The trans-Atlantic quest to find a winning combination of cancer drugs

An exciting new partnership will see a combination of drugs tested in mesothelioma, lung and pancreatic cancers for the first time.

Study sheds new light on asbestos-related cancer

US scientists analysing tumour samples from patients with mesothelioma have mapped out the gene faults associated with the disease in unprecedented detail.

Dampening the immune system improves response to mesothelioma treatment

Suppressing the body's natural defences could improve how well mesothelioma patients respond to certain treatments, a US study suggests.

'Baby boom' carpenters at greatest risk of developing asbestos related cancer

One in 17 British carpenters born in the 1940s will die of mesothelioma - a cancer of the lining of the lung caused by asbestos - according to new research* published in...

Mesothelioma deaths to peak by 2015

Deaths from mesothelioma, an asbestos-related lung cancer, will peak within ten years in the UK and then fall to a much lower level, according to new figures published in...

Asbestos linked to cancer of the ovaries and larynx

Exposure to asbestos, which is known to cause a form of cancer called mesothelioma, has also been shown to cause some cancers of the ovary and larynx (voice box) as well,...

Survey finds widespread ignorance of asbestos, cancer link

A new survey has revealed widespread ignorance of the health risks posed by asbestos, with under a third of tradespeople recognising that it can cause cancer.

NICE to reconsider Alimta ruling

The National Institute of Health and Clinical Excellence (NICE) has said it is to reconsider its decision that a drug for asbestos-related lung cancer should not be...